Hjem › Dermatomyositt › Texas › Houston
Kliniske studier for Dermatomyositt i Houston, TX
5 studier for Dermatomyositt søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
- UT MD Anderson Cancer Center, Houston
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RekruttererFase 2/3
- Houston Methodist Hospital - Accepting Adult Patients, Houston
- University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
RekruttererFase 3
- Nerve & Muscle Center of Texas, Houston
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
RekruttererFase 3
- Nerve & Muscle Center of Texas, Houston
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RekruttererFase 1
- Nerve and Muscle Center of Texas, Houston
Dermatomyositt-studier i andre byer
- Durham, NC8 studier
- Washington, DC7 studier
- New York City, NY5 studier
- Pittsburgh, PA5 studier
- Boston, MA5 studier
- Philadelphia, PA4 studier
- Baltimore, MD4 studier
- Miami, FL4 studier
- Cleveland, OH3 studier
- Jacksonville, FL3 studier
- Aurora, CO3 studier
- Kansas City, KS3 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.